Request For Demo     Request For FreeTrial     Subscribe     Pay Now

Contract Award For 44230303/Wqd/Supply And Delivery Of Chemicals For Research Purpose . S4...


Contract Award Notice

TRR 18148709
Organization Public Utilities Board
Tender No PUB000ETQ23000179
Funded By Self-Funded
Country Singapore , South Eastern Asia
Contract Value 1,162

Work Detail

Contract Award For 44230303/Wqd/Supply And Delivery Of Chemicals For Research Purpose . S4: Norethindrone-2,2,4,6,6,10-D6, Cas No: 2376036-05-2, 5 Mg/ Bottle, Purity Greater Than Or Equal To 98% Atom D , S4: 2,3,7,8-Tetrachlorodibenzo-P-Dioxin, Cas No: 1746-01-6, Mw: 321.97: Purity: 95%, 1Mg/Bottle , S4: 2-Endo,3-Exo,5-Endo,6-Exo,8,8,10,10-Octachlorobornane (Parlar 26), Cas No: 142534-71-2, 10 Ug/Ml In Nonane, 1Ml/Bottle , S4: 2-Endo,3-Exo,5-Endo,6-Exo,8,8,9,10,10-Nonachlorobornane (Parlar 50), Cas No: 6680-80-8, 10 Ug/Ml In Nonane, 1Ml/Bottle , S4: 2,2,5,5,8,9,9,10,10-Nonachlorobornane (Parlar 62), Cas No: 154159-06-5, 10 Ug/Ml In Nonane, 1Ml/Bottle , S4: Us Epa Method 8276 Toxaphene Composite Stock, Cil-Es-5543 Or Equivalent, 8 Compounds, 1000Ng/Ml In Nonane, 1Ml/Bottle , S4: Tetramethylammonium Hydroxide (Tmah) Solution, 25Wt.% In Methanol, 100Ml/Bot , S4: Atorvastatin-D5, Cas No: 222412-82-0, 1 Mg/Bot, Purity Purity Greater Than Or Equal To 98% , S2: Equilin-D4, Cas No: 285979-79-5, Purity Greater Than Or Equal To 98%, 10 Mg/ Bottle , S2: Equilenin-D3, Cas No: 56588-54-6, Purity Greater Than Or Equal To 98%, 5 Mg/ Bottle , S2: Amoxicillin-D4, Cas No: 26787-78-0, Purity Greater Than Or Equal To 95%, 1 Mg/Bottle , S2: Doxycycline-D3 Hyclate, Cas No: 24390-14-5, Purity Greater Than Or Equal To 95%, 1 Mg/Bottle , S2: Ciprofloxacin-D8, Cas No: 85721-33-1, Purity Greater Than Or Equal To 95%, 2.5 Mg/Bottle , S2: Erythromycin-13C-D3, Cas No: 959119-26-7, Purity Greater Than Or Equal To 95%, 1 Mg/Bottle , S2: Clarithromycin-N-Methyl-D3, Cas No: 959119-22-3, Purity Greater Than Or Equal To 97%, 5 Mg/Bottle , S2: Ceftriaxone-D3 Disodium Salt, Cas No: 1132650-38-4, Purity Greater Than Or Equal To 95%, 1 Mg/Bottle , S2: Cloxacillin-13C4 Sodium Salt, Cas No: 642-78-4, Purity Greater Than Or Equal To 95%, 1 Mg/Bottle , S2: Piperacillin-D5, Cas No: 61477-96-1, Purity Greater Than Or Equal To 95%, 1 Mg/Bottle , S2: Sulfamethoxazole-D4, Cas No: 1020719-86-1, Purity Greater Than Or Equal To 95%, 5 Mg/Bottle , S2: Efavirenz-D5, Cas No: 1132642-95-5, Purity Greater Than Or Equal To 95%, 0.5 Mg/Bottle , S2: Ganciclovir-D5, Cas No: 1189966-73-1, Purity Greater Than Or Equal To 95%, 1 Mg/Bottle , S2: Metronidazole-D3, Cas No: 83413-09-6, Purity Greater Than Or Equal To 95%, 1 Mg/Bottle , S2: Clindamycin-D3 Hydrochloride, Cas No: 1356933-72-6, Purity Greater Than Or Equal To 95%, 1 Mg/Bottle , S2: Aciclovir-D4, Cas No: 1185179-33-2, Purity Greater Than Or Equal To 95%, 1 Mg/Bottle , S2: Entecavir-D2, Cas No: 142217-69-4, Purity Greater Than Or Equal To 95%, 1 Mg/Bottle , S2: Lamivudine-13Cd2, Cas No 134678-17-4, Purity Greater Than Or Equal To 95%, 1 Mg/Bottle , S2: Abacavir-D4, Cas No: 1217731-56-0, Purity Greater Than Or Equal To 95%, 1 Mg/Bottle , S2: Cephalexin-D5 Hydrate, Cas No: 23325-78-2 Purity Greater Than Or Equal To 95%, 1 Mg/Bottle , S2: Trimethroprim-D3, Cas No: 1189923-38-3 Purity Greater Than Or Equal To 95%, 1 Mg/Bottle , S2: Tylosin 3-Acetate-D3, Cas No: 63409-10-9 Purity Greater Than Or Equal To 95%, 0.5Mg/Bottle , S2: Tetracycline-D6, Cas No: 60-54-8 Purity Greater Than Or Equal To 95%, 0.5Mg/Bottle , S2: Amoxicillin, Cas No: 26787-78-0, Purity Greater Than Or Equal To 97%, 250 Mg/Bot , S2: Azithromycin, Cas No: 83905-01-4, Purity Greater Than Or Equal To 97%, 100 Mg/Bot , S2: Ceftriaxone, Cas No: 73384-59-5, Purity Greater Than Or Equal To 97%, 100 Mg/Bot , S2: Clindamycin Hydrochloride, Cas No: 21462-39-5, Purity Greater Than Or Equal To 97%, 250 Mg/Bot , S2: Cloxacillin Sodium Salt, Cas No: 7081-44-9, Purity Greater Than Or Equal To 95%, 250 Mg/Bot , S2: Cefazolin, Cas No: 25953-19-9, Purity Greater Than Or Equal To 95 %, 250 Mg/Bot , S2: Entecavir, Cas No: 142217-69-4, Purity Greater Than Or Equal To 97%, 250 Mg/Bot , S2: Ganciclovir, Cas No: 82410-32-0, Purity Greater Than Or Equal To 97%, 100 Mg/Bot , S2: Lamivudine, Cas No: 134678-17-4, Purity Greater Than Or Equal To 97%, 100 Mg/Bot , S2: Abacavir, Cas No:136470-78-5, Purity Greater Than Or Equal To 95%, 100 Mg/Bot , S2: Azithromycin-13Cd3, Cas No: 83905-01-5, Purity Greater Than Or Equal To 95%, 1 Mg/Bottle , S2: 1,4,7,14,17,20-Hexaoxacyclohexacosane-8,13,21,26-Tetrone, Cas No: 314254-68-7, Purity Greater Than Or Equal To 95%, 5Mg/Bot , S2: 3,6,9,16,19,22-Hexaoxabicyclo[22.3.1]Octacosa-1(28),24,26-Triene-2,10,15,23-Tetrone, Cas No: 1394013-66-1,Purity Greater Than Or Equal To 95%, 10Mg/Bot , S2: 3,6,9,17,20,23-Hexaoxatricyclo[23.3.1.1]Triaconta-1(29),11,13,15(30),25,27-Hexaene-2,10,16,24-Tetrone, Cas No: 94693-55-7, Purity Greater Than Or Equal To 95%, 10Mg/Bot , S2: Tris(1-Chloro-2-Propyl) Phosphate, Cas No: 13674-84-5, Purity Greater Than Or Equal To 95%, 250Mg/Bot , S2: 17Beta-Estradiol-D4, Cas 66789-03-5, Purity Greater Than Or Equal To 97%, 10Mg/ Bot , S2: 6Ppd-Quinone (6Ppd-Q), Cas No.:2754428-18-5, 100Mg/Bot , S4: Tylosin, Cas No: 1405-54-5, Purity Greater Than Or Equal To 95%, 250 Mg/Bot , S4: Metformin-D6 Hydrochloride, Cas No:1185166-01-1, 1 Mg/Bot, Purity Greater Than Or Equal To 98% , S4: Valsartan-D9, Cas No:1089736-73-1, 1Mg/Bot, Purity Greater Than Or Equal To 98% , S4: Glipizide-D11, Cas No:1189426-07-0, 1Mg/Bot, Purity Greater Than Or Equal To 98% , S4: Dicofol-D8, 1Mg/Bottle, Trc-D436701-1Mg Or Equivalent , S4: Rifampicin-D3, Cas No: 1262052-36-7, Purity Greater Than Or Equal To 95%, 0.5Mg/Bottle , S4: Cefazolin-13C215n Sodium Salt, Cas No: 1346602-30-9, Purity Greater Than Or Equal To 95%, 1 Mg/Bottle , S4: 17-Beta-Estradiol, Cas No: 50-28-2, Mw: 321.97, Purity: 97%, 1G/Bottle , S1: Ciprofloxacin, Cas No: 85721-33-1, Purity Greater Than Or Equal To 97%, 100 Mg/Bot , S1: Erythromycin, Cas No: 114-07-8, Purity Greater Than Or Equal To 95%, 100 Mg/Bot , S1: Metronidazole, Cas No: 443-48-1, Purity Greater Than Or Equal To 97%, 250 Mg/Bot , S1: Piperacillin, Cas No: 66258-76-2, Purity Greater Than Or Equal To 97%, 100 Mg/Bot , S1: Rifampicin, Cas No: 13292-46-1, Purity Greater Than Or Equal To 95%, 100 Mg/Bot , S1: Tetracycline Hydrochloride, Cas No: 64-75-5, Purity Greater Than Or Equal To 97%, 250 Mg/Bot , S1: Trimethoprim, Cas No: 738-70-5, Purity Greater Than Or Equal To 98%, 250 Mg/Bot , S1: Efavirenz, Cas No:154598-52-4, Purity Greater Than Or Equal To 97%, 100 Mg/Bot , S1: 2-((4-Methylpentan-2-Yl)Amino)-5-(Phenylamino)Cyclohexa-2,5-Diene-1,4-Dione (6Ppd-Quinone) D5, Cas No: 2750119-14-1, 10Mg/Bot , S3: Mpfac-24Es, Mass-Labelled Pfas Extraction Standard Solution, 1000Ng/Ml, 1Ml/Bottle , S3: 2,3,3,3-Tetrafluoro-2-(1,1,2,2,3,3,3-Heptafluoropropoxy)-13C3-Propanoic Acid, (M3hfpo-Da Or Equivalent, 50Ug/Ml In Methanol, 1Ml/Bottle) , S3: Native Pfas Precision And Recovery Standard Solution In Methanol (30 Components), (Wellington: Pfac30par Or Equivalent), 1Ug/Ml In Methanol, 1Ml/Bottle , S3: Sodium Perfluoro-1-Dodecanesulfonate, Cas No: 1260224-54-1, 50Ug/Ml, 1Ml/Bottle (L-Pfdos Or Equivalent) , S3: Sodium Perfluoro-1-Undecanesulfonate, Cas No: 441296-91-9, 50Ug/Ml, 1Ml/Bottle (L-Pfuds Or Equivalent) , S3: Sodium Perfluoro-1-Tridecanesulfonate, Cas No: 174675-49-1, 50Ug/Ml, 1Ml/Bottle (L-Pftrds Or Equivalent) , S3: Native Perfluoroalkyl Ether Carboxylic Acid And Sulfonate Solution, Pfac-Mxg Or Equivalent, (Cas No: 377-73-1, 863090-89-5, 151772-58-6, 113507-82-7, 2000 Ng/Ml In Methanol, 1Ml/Bottle , S3: Perfluoro-4-Oxapentanoic Acid (Pfmpa), Cas No: 377-73-1, At Least 50Ug/Ml, 1Ml/Bottle (Pf4opea Or Equivalent) , S3: Perfluoro-5-Oxahexanoic Acid (Pfmba), Cas No: 863090-89-5, At Least 50Ug/Ml, 1Ml/Bottle (Pf5ohxa Or Equivalent) , S3: Nonafluoro-3,6-Dioxaheptanoic Acid (Nfdha), Cas No: 151772-58-6, At Least 50Ug/Ml, 1Ml/Bottle (3,6-Opfhpa Or Equivalent) , S3: Potassium Perfluoro(2-Ethoxyethane)Sulfonate (Pfeesa), Cas No: 113507-82-7, At Least 50Ug/Ml, 1Ml/Bottle (Pfeesa Or Equivalent) , S3: Mpfac-C-Is, Mass-Labelled Pfas Injection Standards, 2000Ng/Ml In Methanol, 1Ml/Bottle , S3: 6:2Ftab, Cas No: 34455-29-3, 50Ug/Ml, 1Ml/Bottle, N-Cmamp-6:2Fosa Or Equivalent , S3: 3-Perfluoropropyl Propanoic Acid (3:3) (Fprpa), Cas No: 356-02-5, At Least 50Ug/Ml, 1Ml/Bottle, Fprpa Or Equivalent , S3: 3-Perfluoropentyl Propanoic Acid(5:3) (Fpepa), Cas No: 914637-49-3, At Least 50Ug/Ml, 1Ml/Bottle, Fpepa Or Equivalent , S3: 3-Perfluoroheptyl Propanoic Acid(7:3) (Fhppa), Cas No: 812-70-4, At Least 50Ug/Ml, 1Ml/Bottle, Fhppa Or Equivalent , S3: N-Methyl Perfluorooctanesulfonamidoethanol, Cas No: 24448-09-7, At Least 50Ug/Ml, 1Ml/Bottle, N-Mefose-M Or Equivalent , S3: N-Ethyl Perfluorooctanesulfonamidoethanol, Cas No: 1691-99-2, At Least 50Ug/Ml, 1Ml/Bottle, N-Etfose-M Or Equivalent , S3: N-Methyl Perfluorooctanesulfonamide , Heptadecafluoro-N-Methyloctanesulphonamide, Cas No: 31506-32-8, At Least 50Ug/Ml, 1Ml/Bottle, N-Mefosa-M Or Equivalent , S3: N-Ethyl Perfluorooctanesulfonamide, Cas No: 4151-50-2, At Least 50Ug/Ml, 1Ml/Bottle, N-Etfosa-M Or Equivalent , S3: 10:2 Fluorotelomer Sulfonic Acid (10:2 Fts), Cas No: 108026-35-3, At Least 50Ug/Ml, 1Ml/Bottle, 10:2 Fts Or Equivalent , S3: Perfluoro-N-Hexadecanoic Acid (Pfhxda), Cas No: 67905-19-5, 50Ug/Ml, 1Ml/Bottle, Pfhxda Or Equivalent , S3: Perfluorooctadecanoic Acid, Cas No: 16517-11-6, At Least 50Ug/Ml, 1Ml/Bottle, Pfoda Or Equivalent , S3: Perfluorohexanesulfonic Acid, Cas No: 355-46-4, 50Ug/Ml, 1Ml/Bottle, Pfhxs Or Equivalent , S4: Doxycycline Hyclate, Cas No: 24390-14-5, Purity Greater Than Or Equal To 95%, 250 Mg/Bot , S4: Vancomycin-D12, Cas No: 1404-90-6 Purity Greater Than Or Equal To 95%, 1 Mg/Bottle , S4: Cefalexin Monohydrate, Cas No: 23325-78-2, Purity Greater Than Or Equal To 97%, 250 Mg/Bot , S4: Sulfamethoxazole, Cas No: 723-46-6, Purity Greater Than Or Equal To 97%, 250 Mg/Bot , S4: Aciclovir, Cas No: 59277-89-3, Purity Greater Than Or Equal To 97%, 250 Mg/Bot , S4: N-(1,3-Dimethylbutyl)-N-Phenyl-P-Phenylenediamine (6Ppd), Cas No: 793-24-8, 500Mg/Bot , S4: Valsartan, Cas No:137862-53-4, 10Mg/Bot, Purity Greater Than Or Equal To 98% , S4: Atorvastatin, Cas No: 134523-03-8, 5 Mg/Bot, Purity Greater Than Or Equal To 98% , S4: Clopidogrel Hydrogen Sulfate, Cas No:135046-48-9, 5Mg/Bot, Purity Greater Than Or Equal To 98% , S4: Glipizide, Cas No: 29094-61-9, 10Mg/Bot, Purity Greater Than Or Equal To 98% , S4: Tbtc (Tributyltin Chloride), Cas No: 1461-22-9, Product Code: Dre-C17150000 Or Equivalent, 250Mg/Bot , S4: Fentin-Chloride, Cas No: 639-58-7, Product Code: Dre-C13601000 Or Equivalent, 250Mg/Bot , S4: Dibutyltin-Dichloride, Cas No: 683-18-1, Product Code: Dre-C12258000 Or Equivalent, 250Mg/Bot , S4: Di-N-Octyltin Dichloride, Cas No: 3542-36-7, Product Code: Dre-C12837000 Or Equivalent,100Mg/Bot , S4: Clarithromycin, Cas No: 81103-11-9, Purity Greater Than Or Equal To 97%, 250 Mg/Bot , S4: 1,3-Di-O-Tolylguanidine, Cas No: 97-39-2, 100G/Bot , S4: (S)-(+)-Clopidogrel-D3 (Sulfate), 5Mg/Bot, Purity Greater Than Or Equal To 98% , S4: Ortho-Phosphoric Acid, 85%, Cas No: 7664-38-2, 2.5 L/Bot , S4: Brij 35 Solution, 30% W/W In Water, Cas No: 9002-92-0, 100 Ml/Bot , S4: Acetic Acid, Hplc Grade, Purity Greater Than Or Equal To 99.8%, In Glass Bottle, 100Ml/Bottle , S4: Vancomycin Hydrochloride, Cas No: 1404-93-9, Purity Greater Than Or Equal To 93%, 250 Mg/Bot , S4: Metformin, Cas No: 1115-70-4, 500 Mg/Bot, Purity Greater Than Or Equal To 97%

Key Dates

Contract Date 16 Apr 2024

Contact Information

Company Name Sigma-Aldrich Pte. Ltd.
Contract Value 1,162
Contract Date 16 Apr 2024

Complete details of the selected Tender
Organisation Name : Vijaya Bank
Organisation Type : Public Sector Banks Ministry : Ministry of Finance
Tender Ref. No : DIT/DELHIARMB/07052016/1
Tender Title : E-Auction Sale Notice for the properties of M/s Guru Kripa Iron Trading Pvt Ltd, mortgaged to Vijaya Bank and taken possession under the provisions of SARFAESI Act 2002.
Product Category : Land/Building
Sub Category :
Tender Value (INR if not mentioned):
Rs 1,62,00,000/-
EMD :
1620000
Document Cost :
0
Tender Type : Auction
Location : Delhi
First   
Announcement Date :
5-July-2016  
Publication Date on Portal: 5-July-2016 At : 8:03:09 PM  
Last Date of Document Collection :  
8-August-2016 Up To : 5:00 PM  
Last date for  
Submission :
8-August-2016 Up To : 5:00 PM  
Opening Date : 10-August-2016 At : 11:00 AM  
Work Description :
Pre-Qualification :
PreBid Meet Date : --
Tender Document : View Document *
Bid Document : Document Not available
Tech. Document : Document Not available
Sector : Banking, Finance & Insurance
State : Karnataka
 
For further Information Contact:
Name : Santhosh Aili
E-Mail : cbsprog11@vijayabank.co.in
Phone Office : 08025584066
Fax : 08025582747
Address :
City : Bangalore

  download Adobe® Reader®
Adobe® and Get Adobe® Reader® logo are trademarks or registered trademarks of Adobe Systems Inc. in the US and/or other countries.

View Notice Now...

Login with your Social Account for Instant Access to this notice


Tell us about your Product / Services,
We will Find Tenders for you